跳至主要内容
临床试验/CTRI/2026/02/103984
CTRI/2026/02/103984尚未招募Phase 3 4

An interventional study to evaluate the effect of Mustadi Yapana Vasti in the management of Adenomyosis.

DrLeela Ramakrishnan1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2026年2月27日最近更新:

试验速览

阶段
Phase 3 4
状态
尚未招募
发起方
入组人数
40
试验地点
1

研究概览

简要总结

To assess the efficacy of Mustadi Yapana Vasti in Adenomyosis. 

To evaluate changes in myometrium [ USG- TVS] after Mustadi Yapana Vasti in women diagnosed with Asrigdara and documented as Adenomyosis.

To assess clinical improvement in menstrual bleeding [quantified by PBAC score]

To assess clinical improvement in dysmenorrhoea

To measure changes in haemoglobin

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
35.00 Year(s) 至 55.00 Year(s)(—)
性别
Female

入选标准

  • Age group between 35 to 50 years Diagnosed case of Adenomyosis Dysmenorrhea Willing to participate and provide informed consent.

排除标准

  • Use of IUD Co morbid.
  • Diabetes, Hypertension, cardiac disease Polyps, uterine fibroid, malignancy, Coagulopathy, Ovulatory function, Endometrial, Iatrogenic, Endocrine disease [ Hypo/ Hyper Thyroids], non-menstrual causes for bleeding [ foreign body, abortion].

研究者

发起方
DrLeela Ramakrishnan
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

DrLeela Ramakrishnan

Sri Jayendra Saraswathi Ayurveda Medical College and Hospital

研究点 (1)

Loading locations...

相似试验